ADVERTISEMENT
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Altimmune to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September ...

September 7, 2021 GMT

GAITHERSBURG, Md., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the management team will present during a fireside chat at the H.C. Wainwright 23rd Annual Global Investment Conference, being held virtually on September 13-15, 2021.

Details on the H.C. Wainwright fireside chat presentation are as follows:

 Title:   H.C. Wainwright 23rd Annual Global Investment Conference 
     
 Presenters:     Vipin Garg, Ph.D., Chief Executive Officer 
   Scott Harris, M.D., Chief Medical Officer 
     
 Date/Time:   Monday, September 13, 2021 (virtual pre-record available at 7 a.m. EST) 
ADVERTISEMENT

A webcast link to the fireside chat presentation will be accessible on the Events section of the Altimmune website.

About Altimmune

Altimmune is a clinical stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. Our pipeline includes next generation peptide therapeutics for obesity, NASH (ALT-801), and chronic hepatitis B (HepTcell™). For more information, please visit www.altimmune.com.

Follow @Altimmune, Inc. on LinkedIn
Follow @AltimmuneInc on Twitter

Investor & Media Contacts:

Will Brown                                                        
Chief Financial Officer                                                 
Phone: 240-654-1450                                                        
wbrown@altimmune.com